Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair.
Not Applicable
Completed
- Conditions
- Dural TearCerebrospinal Fluid Leak
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Nurami Medical Ltd
- Target Recruit Count
- 92
- Registration Number
- NCT04145544
- Locations
- 🇧🇪
Ziekenhuis Oost-Limburg, Genk, Belgium
🇨🇿St. Anne's University Hospital Brno, Brno, Czechia
🇨🇿Neurochirurgická klinika Přednosta FN Olomouc, Olomouc, Czechia
News
No news found